Randomized phase II trial of erlotinib (E) versus temozolomide (TMZ) or BCNU in recurrent glioblastoma multiforme (GBM): EORTC 26034

被引：0

作者：

Van den Bent, Martin ^{[1
]}

Brandes, Alba

Rampling, Roy ^{[2
]}

Kouwenhoven, Mathilde ^{[3
]}

Kros, Johan M. ^{[4
]}

Carpentier, Antoine ^{[5
]}

Clement, Paul ^{[6
]}

Klughammer, Barbara ^{[7
]}

Bakker, Brenda ^{[8
]}

Lacombe, Denis ^{[9
]}

Gorlia, Thierry ^{[9
]}

机构：

[1] Dr Daniel Den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands

[2] Beatson Oncol Ctr, Glasgow, Lanark, Scotland

[3] EEA, Rotterdam, Netherlands

[4] Erasmus MC, Rotterdam, Netherlands

[5] CHU Pitie Salpetriere, Paris, France

[6] Acad Ziekenhuis, Louvain, Belgium

[7] Hoffmann La Roche AG, Basel, Switzerland

[8] Erasme Univ Hosp, B-1070 Brussels, Belgium

[9] Eortc Data Ctr, Brussels, Belgium

来源：

NEURO-ONCOLOGY | 2007年 / 9卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：522 / 522

页数：1

共 50 条

[41] Phase II study of erlotinib single agent therapy in recurrent glioblastoma multiforme
Vogelbaum, M.
Peereboom, D.
Stevens, G.
Barnett, G.
Brewer, C.
EJC SUPPLEMENTS, 2005, 3 (02): : 135 - 135
[42] A PHASE II TRIAL OF SUNITINIB IN THE TREATMENT OF RECURRENT GLIOBLASTOMA (GBM)
Kreisl, Teri N.
Smith, P.
Iwamoto, Fabio
Sul, Joohee
Butman, John A.
Fine, Howard A.
NEURO-ONCOLOGY, 2010, 12 : 71 - 72
[43] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly diagnosed glioblastoma multiforme: Final results
Peereboom, D. M.
Brewer, C. J.
Sub, J. H.
Stevens, G. H.
Barnett, G. H.
Toms, S. A.
Elson, P.
Vogelbaum, M. A.
Weil, R. J.
NEURO-ONCOLOGY, 2006, 8 (04) : 448 - 448
[44] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly-diagnosed glioblastoma multiforme.
Brewer, CJ
Suh, JH
Stevens, GHJ
Barnett, GH
Toms, S
Vogelbaum, MA
Weil, R
Peereboom, DM
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 130S - 130S
[45] PHASE II AND PHARMACOGENOMICS (PGX) STUDY OF ENZASTAURIN (ENZ) PLUS TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA (GS)
Butowski, Nicholas A.
Lamborn, Kathleen L.
Polley, Mei-Yin C.
Hsieh, Emily
Kivett, Valerie
Page, Margaretta S.
Parvataneni, Rupa
Nicol, Steve
Thornton, Don
Prados, Michael
NEURO-ONCOLOGY, 2009, 11 (05) : 621 - 621
[46] PHASE I/II STUDY OF ENZASTAURIN (ENZ) PLUS TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (XRT) IN PATIENTS (PTS) WITH GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA (GS)
Butowski, N.
Lamborn, K.
Chang, S.
Page, M.
Parvataneni, R.
Chang, S.
Liepa, A. M.
Nicol, S.
Thornton, D.
Prados, M.
NEURO-ONCOLOGY, 2008, 10 (06) : 1073 - 1074
[47] PHASE II TRIAL OF UPFRONT BEVACIZUMAB WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
Ranjan, Tulika
Desjardins, Annick
Peters, Katherine B.
Alderson, Lloyd
Kirkpatrick, John
Herndon, James, II
Bailey, Leighann
Sampson, John
Friedman, Allan H.
Friedman, Henry
Vredenburgh, James J.
NEURO-ONCOLOGY, 2012, 14 : 79 - 79
[48] Phase II/III randomized study of edotecarin vs. temozolomide or nitrosourea in patients with recurrent glioblastoma (GBM): Phase II results
Gilbert, M.
Campone, M.
Brandes, A. A.
Gertler, S.
Green, S.
Fowst, C.
Caulkins, J.
Ingrosso, A.
Foley, M.
EJC SUPPLEMENTS, 2005, 3 (02): : 136 - 136
[49] BEVACIZUMAB (BV) IN COMBINATION TO TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): A PHASE 2 TRIAL
Desjardins, Annick
Reardon, David A.
Peters, Katherine B.
Herndon, James
Kirkpatrick, John
Gururangan, Sridharan
Sampson, John H.
Friedman, Allan H.
Friedman, Henry
Vredenburgh, James J.
NEURO-ONCOLOGY, 2009, 11 (05) : 634 - 634
[50] A PHASE II TRIAL OF EVEROLIMUS IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
Cloughesy, Timothy
Raizer, J.
Drappatz, J.
Gerena-Lewis, M.
Rogerio, J.
Yacoub, S.
Desjardin, A.
NEURO-ONCOLOGY, 2011, 13 : 42 - 43

← 1 2 3 4 5 →